Literature DB >> 28468591

Mitochondrial dynamics and cancer.

Paola Maycotte1,2, Alvaro Marín-Hernández3, Miriam Goyri-Aguirre2, Maricruz Anaya-Ruiz2, Julio Reyes-Leyva2, Paulina Cortés-Hernández2.   

Abstract

Cancer is among the leading causes of death worldwide, and the number of new cases continues to rise. Despite recent advances in diagnosis and therapeutic strategies, millions of cancer-related deaths occur, indicating the need for better therapies and diagnostic strategies. Mitochondria and metabolic alterations have been recognized as important for cancer progression. However, a more precise understanding of how to manipulate mitochondria-related processes for cancer therapy remains to be established. Mitochondria are highly dynamic organelles which continually fuse and divide in response to diverse stimuli. Participation in the aforementioned processes requires a precise regulation at many levels that allows the cell to couple mitochondrial activity to nutrient availability, biosynthetic demands, proliferation rates, and external stimuli. The many functions of these organelles are intimately linked to their morphology. Recent evidence suggests an important link between mitochondrial morphology and disease, including neurodegenerative, inflammatory diseases and cancer. Here, we review recent advances in the understanding of mitochondrial dynamics with a special focus on its relationship to tumor progression.

Entities:  

Keywords:  Mitochondria; cancer; mitochondrial fission; mitochondrial fusion

Mesh:

Year:  2017        PMID: 28468591     DOI: 10.1177/1010428317698391

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  41 in total

Review 1.  Proteins moonlighting in tumor metabolism and epigenetics.

Authors:  Lei Lv; Qunying Lei
Journal:  Front Med       Date:  2021-01-02       Impact factor: 4.592

Review 2.  Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer.

Authors:  Hang Yang; Bin Wei; Bing Hu
Journal:  Inflamm Res       Date:  2021-09-21       Impact factor: 4.575

3.  Mitochondrial structural alterations in ovarian cancer patient-derived xenografts resistant to cisplatin.

Authors:  Francesca Ricci; Alessandro Corbelli; Roberta Affatato; Rosaria Chilà; Michela Chiappa; Laura Brunelli; Robert Fruscio; Roberta Pastorelli; Fabio Fiordaliso; Giovanna Damia
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

4.  Cystathionine β-synthase regulates mitochondrial morphogenesis in ovarian cancer.

Authors:  Prabir Kumar Chakraborty; Brennah Murphy; Soumyajit Banerjee Mustafi; Anindya Dey; Xunhao Xiong; Geeta Rao; Sarwat Naz; Min Zhang; Da Yang; Danny N Dhanasekaran; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  FASEB J       Date:  2018-03-01       Impact factor: 5.191

5.  Mitochondria as Target for Tumor Management of Hemangioendothelioma.

Authors:  Gayle M Gordillo; Ayan Biswas; Kanhaiya Singh; Abhishek Sen; Poornachander R Guda; Caroline Miller; Xueliang Pan; Savita Khanna; Enrique Cadenas; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2020-07-28       Impact factor: 8.401

6.  Effect of luteinizing hormone concentration on transcriptome and subcellular organelle phenotype of ovarian granulosa cells.

Authors:  Yu-Ting Wan; Shan Liu; Shan-Ke Zhao; Yi-Yang Luo; Ya-Su Lv; Dan-Ni Qu; Ming-Hui Liu; Yuan Li
Journal:  J Assist Reprod Genet       Date:  2021-01-14       Impact factor: 3.412

7.  Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries.

Authors:  Xiaonan Zhang; Mihir Shetty; Valentino Clemente; Stig Linder; Martina Bazzaro
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 8.  Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance.

Authors:  Ilaria Genovese; Marianna Carinci; Lorenzo Modesti; Gianluca Aguiari; Paolo Pinton; Carlotta Giorgi
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

9.  Human placenta-derived mesenchymal stem cells induce trophoblast invasion via dynamic effects on mitochondrial function.

Authors:  Jin Seok; Sujin Jun; Jinki Cho; Sohea Park; Jung Ok Lee; Gi Jin Kim
Journal:  J Cell Physiol       Date:  2021-02-24       Impact factor: 6.513

10.  Combined Anticancer Effect of Plasma-Activated Infusion and Salinomycin by Targeting Autophagy and Mitochondrial Morphology.

Authors:  Takashi Ando; Manami Suzuki-Karasaki; Miki Suzuki-Karasaki; Jiro Ichikawa; Toyoko Ochiai; Yukihiro Yoshida; Hirotaka Haro; Yoshihiro Suzuki-Karasaki
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.